BCR and B-cell chronic lymphocytic leukemia: miR-155 targets SHIP-1 [117] and high expression of miR-155 is associated with UM-CLL cases [118], possibly leading to diminished ability to initiate the negative BCR signaling associated with anergy [86, 91, 92].